The Pure ChainIpamorelin
Regulatory status
Placed in Category 2 of FDA's 503A bulk drug substances list — significant safety risks identified. Not eligible for 503A compounding. Available to verified facilities for research and manufacturing use.
Summary
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue containing two aminoisobutyric acid residues. The unnatural residues make coupling yields lower than the residue count suggests, and incomplete coupling is the dominant impurity route.
It is one of the highest-volume peptides in the market we serve, which means price dispersion between manufacturers is wide and the analytical package is the only reliable basis for comparison.
Typical related substances
Typical related substances are des-Aib deletion sequences, D-tryptophan epimers and residual acetate and water.
Regulatory note
Category 2 of the FDA 503A bulk drug substances list. Not eligible for 503A compounding.
Regulatory status shown is our current understanding and is not legal advice. Each facility is responsible for confirming eligibility for its own licence type before purchase.